Korro Bio (KRRO) Tops Q2 EPS by 24c

Korro Bio (NASDAQ: KRRO) reported Q2 EPS of ($1.07), $0.24 better than the analyst estimate of ($1.31). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $507.44 thousand.

For earnings history and earnings-related data on Korro Bio (KRRO) click here.

You May Also Be Interested In

• Crude Inventory 0.4M Barrels Last Week - EIA
• You Don't Need $1,000 to Start a Business. You Might Not Even Need $100
• Biopharma Circular Systems Will Move Beyond Park Benches